Aperio Group’s Teva Pharmaceutical Industries TEVA Stock Holding History
Bought
Maintained
Sold
Other funds holding TEVA
Aperio Group's TEVA Position: Q4 2020 in Review
Aperio Group reduced its Teva Pharmaceutical Industries (TEVA) stake by 52% in Q4 2020, selling an estimated $1.29M and leaving 122,805 shares worth $1.18M. The position accounts for ﹤0.01% of the portfolio, ranked #1498.
Aperio Group first reported a position in TEVA in Q2 2013 and has held it in 30 quarters since. The position peaked at $28.9M in Q4 2015. 451 funds tracked by Wall St. Rank hold TEVA as of Q4 2020.
- Aperio Group held 122,805 shares of Teva Pharmaceutical Industries worth $1.18M as of Q4 2020.
- Aperio Group sold 134,522 Teva Pharmaceutical Industries shares in Q4 2020, an estimated $1.29M.
- Teva Pharmaceutical Industries made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #1498 holding.
- Aperio Group first reported a position in Teva Pharmaceutical Industries in Q2 2013 and has held it in 30 quarters since.
- Aperio Group's Teva Pharmaceutical Industries position peaked at $28.9M in Q4 2015.
- 451 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries as of Q4 2020.
Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.